Differential gene expression pattern in early gastric cancer by an integrative systematic approach

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1675-1682

  Nam, Seungyoon ^a   Lee, Jieun ^a   Goh, Sung Ho ^a   Hong, Seung Hyun ^a   Song, Naaleum ^a   Jang, Sang Geun ^a   Choi, Il Ju ^a   Lee, Yeon Su ^a  

^a National Cancer Center   (South Korea)

Author keywords

Estrogen receptor ; Gastric cancer; Metalloproteinases; Metastasis; Microarray

Indexed keywords

COLLAGENASE 3; ESTROGEN RECEPTOR ALPHA; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; STROMELYSIN; STROMELYSIN 2;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; EARLY CANCER; EARLY GASTRIC CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

ADULT; AGED; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84867786163     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1621     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Vecchi M, Nuciforo P, Romagnoli S, et al: Gene expression analysis of early and advanced gastric cancers. Oncogene 26: 4284-4294, 2007. (Pubitemid 46975798)
3. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006. (Pubitemid 43329250)
4. Nam SY, Choi IJ, Park KW, et al: Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 21: 855-860, 2009.
5. Takeno A, Takemasa I, Doki Y, et al: Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 99: 1307-1315, 2008.
6. Yamada Y, Arao T, Gotoda T, et al: Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci 99: 2193-2199, 2008.
7. Cui J, Li F, Wang G, Fang X, Puett JD and Xu Y: Gene-expression signatures can distinguish gastric cancer grades and stages. PLoS One 6: e17819, 2011.
8. Economescu MC, Necula LG, Dragu D, et al: Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology 57: 1453-1464, 2010.
9. Maere S, Heymans K and Kuiper M: BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21: 3448-3449, 2005. (Pubitemid 41222459)
10. Kanehisa M, Goto S, Furumichi M, Tanabe M and Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-D360, 2010.
11. Newman JC and Weiner AM: L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol 6: R81, 2005.
12. Enerly E, Steinfeld I, Kleivi K, et al: miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6: e16915, 2011.
13. Lukk M, Kapushesky M, Nikkila J, et al: A global map of human gene expression. Nat Biotechnol 28: 322-324, 2010.
14. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
15. Roy R, Yang J and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297, 2009.
16. Foley J, Nickerson NK, Nam S, et al: EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol 21: 951-960, 2010.
17. Murray GI, Duncan ME, Arbuckle E, Melvin WT and Fothergill JE: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43: 791-797, 1998. (Pubitemid 28539658)
18. Clark IM, Swingler TE, Sampieri CL and Edwards DR: The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40: 1362-1378, 2008.
19. Glynn SA, Prueitt RL, Ridnour LA, et al: COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 10: 626, 2010.
20. Witton CJ, Hawe SJ, Cooke TG and Bartlett JM: Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 45: 47-54, 2004. (Pubitemid 38969561)
21. Fukata M and Abreu MT: Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 27: 234-243, 2008.